In December 2020, the European Medicines Agency (EMA) experienced a cyberattack which resulted in the exploitation of classified documents and emails. Among the documents was an email from a high-ranking EMA official who outlined various concerns about mRNA vaccine manufacturing.
Leaked emails show EMA’s initial hesitancy regarding mRNA vaccine platform
